Production of recombinant monoclonal antibodies (mAbs) for therapeutic use is a multibillion dollar industry. At present, mammalian cell lines are the workhorses of the biotechnology industry, due to ...
Process development and optimization is critical to enhancing the productivity of various cell lines. Nutrient requirements for peak productivity can be clone and process specific. Implementing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback